Abstract
Purpose
The purpose of this study was to explore the presence of autoimmune manifestations and characterize the autoantibody production in a cohort of patients with Aicardi–Goutières syndrome (AGS).
Methods
Seventeen patients with a genetically-confirmed diagnosis of AGS were recruited. At the time of enrollment, past medical and family history was reviewed, looking for possible signs or symptoms of autoimmune disorders. Blood samples were taken, for the detection of a panel of autoantibodies: anti-nuclear, anti-double-stranded-DNA, anti-nucleosome, anti-extractable nuclear antigens, anti-cardiolipin IgG/IgM, anti-β2glycoprotein I IgG/IgM, and anti-neutrophil cytoplasmic. We also measured complement levels determined as C3 and C4 quantification and total complement activity, measured as CH50.
Results
Nine of seventeen patients presented with at least one first- or second-degree relative with a history of autoimmune diseases (the childrens’ mother or grand-mother in the majority of cases). A specific autoimmune disease was present in only one AGS patient, namely an autoimmune thyroiditis. Autoantibodies were present in 9/17 patients, with different patterns of positivity. Complement levels were normal in all the patients. There was no correlation between auto-antibody production and personal or family history of autoimmune diseases.
Conclusions
Definite autoimmune diseases are not common in patients with AGS. Autoantibodies are mainly directed towards nucleic acids-containing elements but seem not to be pathogenic and, rather, may represent an epiphenomenon of the enhanced interferon production.
Similar content being viewed by others
Abbreviations
- CSF:
-
Cerebrospinal fluid
- CNS:
-
Central nervous system
References
Dale RC, Tang SP, Heckmatt JZ, Tatnall FM. Familial systemic lupus erythematosus and congenital infection-like syndrome. Neuropediatrics. 2000;31:155–8.
Aicardi J, Goutières F. A progressive familial encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol. 1984;15:49–54.
Crow YJ, Chase DS, Lowenstein Schmidt J, Szynkiewicz M, Forte GM, Gornall HL, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A. 2015;167:296–312.
Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis Rheum. 2010;62(5):1469–77.
Fazzi E, Cattalini M, Orcesi S, Tincani A, Andreoli L, Balottin U, et al. Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? Autoimmun Rev. 2013;12(4):506–9.
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and validation of a gross motor function classification system for children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23.
Eliasson AC, Krumlinde-Sundholm L, Rösblad B, Beckung E, Arner M, Ohrvall AM, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48:549–54.
Hidecker MJ, Paneth N, Rosenbaum PL, Kent RD, Lillie J, Eulenberg JB, et al. Developing and validating the communication function classification system for individuals with cerebral palsy. Dev Med Child Neurol. 2011;53:704–10.
Pincus T, Schur PH, Rose JA, Decker JL, Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Eng J Med. 1969;281:701–5.
Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determination—an operative project of the European Antiphospholipid Forum. Thromb Haemost. 2001;86:575–83.
Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;81(4):713–25.
Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case–control study. Lancet Neurol. 2013;12(12):1159–69.
Crow YJ. Type I, interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011;1238:91–8.
De Laet C, Goyens P, Christophe C, Ferster A, Mascart F, Dan B. Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutieres syndrome. Neuropediatrics. 2005;36:399–402.
Rasmussen M, Skullerud K, Bakke SJ, Lebon P, Jahnsen FL. Cerebral thrombotic microangiopaty and antiphospholipid antibodies in Aicardi-Goutieres syndrome—report of two sisters. Neuropediatrics. 2005;36:40–4.
Dale RC, Gornall H, Singh-Grewal D, Alcausin M, Rice GI, Crow YJ. Familial Aicardi-Goutieres Syndrome due to SAMHD1 mutations is associated with chronic arthropaty and contractures. Am J Med Genet A. 2010;152A:938–42.
Cuadrado E, Vanderver A, Brown KJ, Sandza A, Takanohashi A, Jansen MH, et al. Aicardi-Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies. Ann Rheum Dis. 2015;74(10):1931–9.
Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature. 2015;517(7532):89–93.
Olivieri I, Cattalini M, Tonduti D, La Piana R, Uggetti C, Galli J, et al. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient. Lupus. 2013;22(10):1064–9.
Biggioggero M, Gabbriellini L, Meroni PL. Type I interferon therapy and its role in autoimmunity. Autoimmunity. 2010;43(3):284–54.
Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J Autoimm. 2008;30(1–2):51–7.
Schmidt JL, Olivieri I, Vento JM, Fazzi E, Gordish-Dressman H, Orcesi S, et al. Family history of autoimmune disease in patients with Aicardi-Goutières syndrome. Clin Dev Immunol. 2012;2012:206730.
Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet. 2007;39(9):1065–7.
Günther C, Kind B, Reijns MA, Berndt N, Martinez-Bueno M, Wolf C, et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J Clin Invest. 2015;125(1):413.
Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371(6):507–18.
Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg MC, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 2014;124(12):5516–20.
Acknowledgments
The authors would like to thank Prof. Yanick Crow and Dr. Gillian Rice for performing genetic analysis in most of the patients included in this work and Prof. Crow for critically reviewing the manuscript.
Authorship Contributions
M.C., J.C., L.A., E.F, A.T., and S.O. designed the study. M.C., J.C., E.F, S.O., and I.O. recruited and evaluated the patients. L.A., M.F., G.A., and A.T. performed the laboratory tests. M.C., J.G., and L.A. wrote the manuscript. E.F., A.T., and S.O. reviewed the manuscript. M.C. coordinated the study and the manuscript preparation. The IAGSA study group is a group of physicians and biologists from the Spedali Civili di Brescia and from the Mondino Institute in Pavia, dedicated to the care of patients with AGS and to foster research in the field. All the IAGSA study group members participated in different phases of the study and reviewed the manuscript before submission.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Funding
Part of this work was supported by the European Union’s Seventh Framework Programme (FP7/2007-2013) (S.O.); CARIPLO Foundation (E.F.) and Regione Lombardia (E.F.).
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
All coauthors have reviewed the manuscript and have contributed in a substantive and intellectual manner to the work described.
F. Bettera, M. Bianchi, N. Carabellese, M. De Simone, R. Ferraro, F. Gavazzi, S. Giliani, G. Gualdi, A. Meini, I. Parissenti, D. Vairo, A. Zanola were members of IAGSA study group.
Rights and permissions
About this article
Cite this article
Cattalini, M., Galli, J., Andreoli, L. et al. Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome. J Clin Immunol 36, 693–699 (2016). https://doi.org/10.1007/s10875-016-0325-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-016-0325-y